Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To elucidate the molecular basis for mitochondrial dysfunction, which has been implicated in the pathogenesis of diabetes complications. RESEARCH DESIGN AND METHODS: Mitochondrial matrix and membrane fractions were generated from liver, brain, heart, and kidney of wild-type and type 1 diabetic Akita mice. Comparative proteomics was performed using label-free proteome expression analysis. Mitochondrial state 3 respirations and ATP synthesis were measured, and mitochondrial morphology was evaluated by electron microscopy. Expression of genes that regulate mitochondrial biogenesis, substrate utilization, and oxidative phosphorylation (OXPHOS) were determined. RESULTS: In diabetic mice, fatty acid oxidation (FAO) proteins were less abundant in liver mitochondria, whereas FAO protein content was induced in mitochondria from all other tissues. Kidney mitochondria showed coordinate induction of tricarboxylic acid (TCA) cycle enzymes, whereas TCA cycle proteins were repressed in cardiac mitochondria. Levels of OXPHOS subunits were coordinately increased in liver mitochondria, whereas mitochondria of other tissues were unaffected. Mitochondrial respiration, ATP synthesis, and morphology were unaffected in liver and kidney mitochondria. In contrast, state 3 respirations, ATP synthesis, and mitochondrial cristae density were decreased in cardiac mitochondria and were accompanied by coordinate repression of OXPHOS and peroxisome proliferator–activated receptor (PPAR)-γ coactivator (PGC)-1α transcripts. CONCLUSIONS: Type 1 diabetes causes tissue-specific remodeling of the mitochondrial proteome. Preservation of mitochondrial function in kidney, brain, and liver, versus mitochondrial dysfunction in the heart, supports a central role for mitochondrial dysfunction in diabetic cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, mRNA levels of transcriptional regulators of mitochondrial mass and function (e.g., Pgc1a, Pgc1b, Tfam) were downregulated in Akita mouse hearts (59).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in rodents have concluded that the brain may be spared from alterations to mitochondrial morphology and function in T1D (59,68,69).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [59]
In the citing paper
“Studies from Akita T1D mice suggest that morphology and function of renal mitochondria are minimally affected (59).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Stereological Principles for Morphometry in Electron Microscopic Cytology
Weibel, E. R. (1969) · International Review of Cytology · doi:10.1016/s0074-7696(08)61637-x · Cited by 1,946
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 1×
“For example, myocardial fatty acid oxidation (FAO) and hepatic gluconeogenesis are increased (3,4).”
BackgroundMootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00926-7 · Cited by 889
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., et al. (2007) · Diabetes · doi:10.2337/db07-0481 · Cited by 586
Self-citationYoshioka, M., Kayo, T., Ikeda, T., & Koizuni, A. (1997) · Diabetes · doi:10.2337/diab.46.5.887 · Cited by 534
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480 · cited 1×
“Moreover, activation of signaling cascades, such as the PGC-1α signaling pathway, may in turn modulate gene expression of OXPHOS proteins and enzymes of energy substrate metabolism (4-7).”
Background
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Nevertheless, there are a number of studies that have shown mitochondrial functional abnormalities at sites of diabetic complications, and this remains an area of active research interest (70, 105, 122, 505, 542, 590, 685).”
BackgroundDiabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Self-citationBasic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Self-citationDiabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Mitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
Pinti, M. V., Fink, G. K., Hathaway, Q. A., Durr, A. J., Kunovac, A., & Hollander, J. M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2018 · Cited by 427
Villena, J. A. (2015) · The FEBS Journal · doi:10.1111/febs.13175 · Cited by 405
Repairing mitochondrial dysfunction in disease
Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337
Rodent models of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001941 · Cited by 285
Self-citationObesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Mitochondria in the diabetic heart
Bugger, H., & Abel, E. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq239 · Cited by 260
Self-citationMitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
Higgins, G. C., & Coughlan, M. T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12503 · Cited by 250
Rosca, M. G., Vazquez, E. J., Chen, Q., Kerner, J., Kern, T. S., & Hoppel, C. L. (2012) · Diabetes · doi:10.2337/db11-1437 · Cited by 218
Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure
Bugger, H., Schwarzer, M., Chen, D., Schrepper, A., Amorim, P. A., Schoepe, M., Nguyen, T. D., Mohr, F. W., Khalimonchuk, O., Weimer, B. C., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp344 · Cited by 211
Self-citationPrevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
Chacko, B. K., Reily, C., Srivastava, A., Johnson, M. S., Ye, Y., Ulasova, E., Agarwal, A., Zinn, K. R., Murphy, M. P., Kalyanaraman, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100308 · Cited by 204
Altered mitochondrial function in insulin-deficient and insulin-resistant states
Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120843 · Cited by 202
SIRT3 deficiency impairs mitochondrial and contractile function in the heart
Koentges, C., Pfeil, K., Schnick, T., Wiese, S., Dahlbock, R., Cimolai, M. C., Meyer-Steenbuck, M., Cenkerova, K., Hoffmann, M. M., Jaeger, C., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0493-6 · Cited by 200
Self-citationOf mice and men: models and mechanisms of diabetic cardiomyopathy
Riehle, C., & Bauersachs, J. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 196
“Based on the mechanistic insight gained from rodent studies, the mechanisms for decreased mitochondrial oxidative capacity [5, 26–29, 34–36, 74, 95, 117, 179, 180, 219] include altered mitochondrial ultrastructure [25, 26, 29, 179, 180], proteomic remodelling [35, 88, 180, 200], and oxidative damage of”
BackgroundSelf-citationMitochondrial dysfunction and complications associated with diabetes
Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
Peng, M.-L., Fu, Y., Wu, C.-W., Zhang, Y., Ren, H., & Zhou, S.-S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.907757 · Cited by 179
Insulin resistance in type 1 diabetes mellitus
Kaul, K., Apostolopoulou, M., & Roden, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.002 · Cited by 176
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Byrne, N. J., Rajasekaran, N. S., Abel, E. D., & Bugger, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.046 · Cited by 174
Self-citationYan, W., Zhang, H., Liu, P., Wang, H., Liu, J., Gao, C., Liu, Y., Lian, K., Yang, L., Sun, L., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0329-1 · Cited by 169
Mitochondrial NAD + /NADH Redox State and Diabetic Cardiomyopathy
Berthiaume, J. M., Kurdys, J. G., Muntean, D. M., & Rosca, M. G. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7415 · Cited by 168
The role of aberrant mitochondrial bioenergetics in diabetic neuropathy
Chowdhury, S. K. R., Smith, D. R., & Fernyhough, P. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.016 · Cited by 166
Dabkowski, E. R., Baseler, W. A., Williamson, C. L., Powell, M., Razunguzwa, T. T., Frisbee, J. C., & Hollander, J. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00267.2010 · Cited by 165
Mitochondrial Dysfunction in Diabetic Neuropathy: a Series of Unfortunate Metabolic Events
Fernyhough, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0671-9 · Cited by 164
Mitochondrial biogenesis and the development of diabetic retinopathy
dos Santos, J. M., Tewari, S., Goldberg, A. F. X., & Kowluru, R. A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.017 · Cited by 164
Pollak, N. M., Hoffman, M., Goldberg, I. J., & Drosatos, K. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.09.001 · Cited by 160
Mitochondrial stress and the pathogenesis of diabetic neuropathy
Fernyhough, P., Chowdhury, S. R., & Schmidt, R. E. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.55 · Cited by 158
KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy
Kyriazis, I. D., Hoffman, M., Gaignebet, L., Lucchese, A. M., Markopoulou, E., Palioura, D., Wang, C., Bannister, T. D., Christofidou‐Solomidou, M., Oka, S., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316738 · Cited by 158
Xie, S., Liu, S., Zhang, T., Shi, W., Xing, Y., Fang, W., Zhang, M., Chen, M.-Y., Xu, S., Fan, M.-Q., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065603 · Cited by 157
Baseler, W. A., Dabkowski, E. R., Williamson, C. L., Croston, T. L., Thapa, D., Powell, M. J., Trust T. Razunguzwa, & Hollander, J. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00423.2010 · Cited by 151
Ilkun, O. L., & Boudina, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270003 · Cited by 147
Akude, E., Zherebitskaya, E., Chowdhury, S. K. R., Smith, D. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Diabetes · doi:10.2337/db10-0818 · Cited by 145
Chowdhury, S. K. R., Zherebitskaya, E., Smith, D. R., Akude, E., Chattopadhyay, S., Jolivalt, C. G., Calcutt, N. A., & Fernyhough, P. (2010) · Diabetes · doi:10.2337/db09-1299 · Cited by 144
Mitochondrial Morphology in Metabolic Diseases
Galloway, C. A., & Yoon, Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4779 · Cited by 140
Mitochondrial Dynamics in Diabetic Cardiomyopathy
Galloway, C. A., & Yoon, Y. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6293 · Cited by 132
miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart
Baseler, W. A., Thapa, D., Jagannathan, R., Dabkowski, E. R., Croston, T. L., & Hollander, J. M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00137.2012 · Cited by 126
Ježek, P., Jabůrek, M., Holendová, B., Engstová, H., & Dlasková, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0173 · Cited by 125
Jagannathan, R., Thapa, D., Nichols, C. E., Shepherd, D. L., Stricker, J. C., Croston, T. L., Baseler, W. A., Lewis, S. E., Martinez, I., & Hollander, J. M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.115.001067 · Cited by 119
Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function
Drosatos, K., Pollak, N. M., Pol, C. J., Ntziachristos, P., Willecke, F., Valenti, M.-C., Trent, C. M., Hu, Y., Guo, S., Aifantis, I., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306383 · Cited by 119
Diabetic Retinopathy, Superoxide Damage and Antioxidants
dos Santos, J. M., Mohammad, G., Zhong, Q. P. W., & Kowluru, R. A. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480507 · Cited by 116
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart
Riehle, C., Wende, A. R., Sena, S., Pires, K. M., Pereira, R. O., Zhu, Y., Bugger, H., Frank, D., Bevins, J., Chen, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71171 · Cited by 114
Self-citationUbiquitin and Receptor-Dependent Mitophagy Pathways and Their Implication in Neurodegeneration
Fritsch, L. E., Moore, M. E., Sarraf, S. A., & Pickrell, A. M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.015 · Cited by 110
Insulin signaling in the heart
Abel, E. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2021 · Cited by 108
Self-citationEftekharpour, E., & Fernyhough, P. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0152 · Cited by 104
Vazquez, E. J., Berthiaume, J. M., Kamath, V. G., Achike, O., Buchanan, E., Montano, M. M., Chandler, M. P., Miyagi, M., & Rosca, M. G. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv183 · Cited by 103
Aubert, G., Vega, R. B., & Kelly, D. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.015 · Cited by 101
Baseler, W. A., Dabkowski, E. R., Jagannathan, R., Thapa, D., Nichols, C. E., Shepherd, D. L., Croston, T. L., Powell, M. J., Trust T. Razunguzwa, Lewis, S. E., et al. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00249.2012 · Cited by 99
Guidelines on models of diabetic heart disease
Heather, L. C., Hafstad, A. D., Halade, G. V., Harmancey, R., Mellor, K. M., Mishra, P. K., Mulvihill, E. E., Nabben, M., Nakamura, M., Rider, O. J., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00058.2022 · Cited by 97
Pulinilkunnil, T., Kienesberger, P. C., Nagendran, J., Waller, T. J., Young, M. E., Kershaw, E. E., Korbutt, G. S., Haemmerle, G., Zechner, R., & Dyck, J. R. B. (2013) · Diabetes · doi:10.2337/db12-0927 · Cited by 97
Wende, A. R., O'Neill, B. T., Bugger, H., Riehle, C., Tuinei, J., Buchanan, J., Tsushima, K., Wang, L., Caro, P., Guo, A., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01109-14 · Cited by 95
Self-citationChowdhury, S. K. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.06.007 · Cited by 82
Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0249 · Cited by 77
Zhang, L., Yu, C. R., Vasquez, F. E., Galeva, N., Onyango, I. G., Swerdlow, R. H., & Dobrowsky, R. T. (2009) · Journal of Proteome Research · doi:10.1021/pr900818g · Cited by 75
Pathological Significance of Mitochondrial Glycation
Pun, P. B. L., & Murphy, M. P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/843505 · Cited by 71
Mitochondria in metabolic disease: Getting clues from proteomic studies
Peinado, J. R., Díaz‐Ruiz, A., Frühbeck, G., & Malagón, M. M. (2014) · PROTEOMICS · doi:10.1002/pmic.201300376 · Cited by 69
Genetic loss of insulin receptors worsens cardiac efficiency in diabetes
Bugger, H., Riehle, C., Jaishy, B. P., Wende, A. R., Tuinei, J., Chen, D., Soto, J. E., Pires, K. M. P., Boudina, S., Theobald, H. A., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.001 · Cited by 69
Self-citationWarren, J. S., Oka, S., Zablocki, D., & Sadoshima, J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00103.2017 · Cited by 69
Cellular Stress and General Pathological Processes
Gusev, E. Y., & Zotova, N. V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319114641 · Cited by 69
Lactosylceramide contributes to mitochondrial dysfunction in diabetes
Novgorodov, S. A., Riley, C. L., Yu, J., Keffler, J. A., Clarke, C. J., Laer, A. O. V., Baicu, C. F., Zile, M. R., & Gudz, T. I. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m060061 · Cited by 68
Beaudoin, M., Perry, C. G. R., Arkell, A. M., Chabowski, A., Simpson, J. A., Wright, D. C., & Holloway, G. P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270538 · Cited by 67
Lumini-Oliveira, J., Magalhães, J., Pereira, C. V., Moreira, A. C., Oliveira, P. J., & Ascensão, A. (2011) · Mitochondrion · doi:10.1016/j.mito.2010.07.005 · Cited by 66
Sharma, D. R., Sunkaria, A., Wani, W. Y., Sharma, R. K., Kandimalla, R. J. L., Bal, A., & Gill, K. D. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.012 · Cited by 66
A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy
Zhang, X., & Chen, C. (2012) · Endocrine · doi:10.1007/s12020-012-9623-1 · Cited by 65
AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation
Zhan, J., Jin, K., Xie, R., Fan, J., Tang, Y., Chen, C., Li, H., & Wang, D. W. (2023) · Circulation · doi:10.1161/circulationaha.123.065546 · Cited by 61
Seref-Ferlengez, Z., Maung, S., Schaffler, M. B., Spray, D. C., Suadicani, S. O., & Thi, M. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155107 · Cited by 60
Sulfur Dioxide Contributes to the Cardiac and Mitochondrial Dysfunction in Rats
Qin, G., Wu, M., Wang, J., Xu, Z., Xia, J., & Sang, N. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw048 · Cited by 60
Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
Sung, M. M. Y., Hamza, S. M., & Dyck, J. R. B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6305 · Cited by 59
The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy
Ussher, J. R. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.891939 · Cited by 59
Mitochondrial dysfunction and pancreatic islet β‑cell failure (Review)
Sha, W., Hu, F., & Bu, S. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9396 · Cited by 58
The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy
Sanganalmath, S. K., Dubey, S., Veeranki, S., Narisetty, K. K., & Krishnamurthy, P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01755-1 · Cited by 58
Post‐translational modifications of the cardiac proteome in diabetes and heart failure
Wende, A. R. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500052 · Cited by 57
Fernyhough, P., & McGavock, J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00027-8 · Cited by 57
Zabielski, P., Lanza, I. R., Gopala, S., Holtz Heppelmann, C. J., Bergen, H. R., Dasari, S., & Nair, K. S. (2016) · Diabetes · doi:10.2337/db15-0823 · Cited by 54
“Proteome analyses in heart muscle found upregulation (19) or downregulation (20) of b-oxidation proteins in different diabetic models.”
BackgroundSpecialized compartments of cardiac nuclei exhibit distinct proteomic anatomy
Franklin, S., Zhang, M. J., Chen, H., Paulsson, A. K., Mitchell-Jordan, S. A., Li, Y., Ping, P., & Vondriska, T. M. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.000703 · Cited by 54
HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy
Lee, T.-I., Kao, Y., Tsai, W., Chung, C., Chen, Y., & Chen, Y.-J. (2016) · PPAR Research · doi:10.1155/2016/5938740 · Cited by 53
Mitochondrial proteomics—a tool for the study of metabolic disorders
Gregersen, N., Hansen, J., & Palmfeldt, J. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9480-3 · Cited by 51
Wu, L., Guo, X., Hartson, S. D., Davis, M. A., He, H., Medeiros, D. M., Wang, W., Clarke, S. L., Lucas, E. A., Smith, B. J., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600576 · Cited by 48
Wang, L., Chen, H., Huang, K., & Zheng, L. (2012) · Glia · doi:10.1002/glia.22405 · Cited by 47
Kcne2 Deletion Creates a Multisystem Syndrome Predisposing to Sudden Cardiac Death
Hu, Z., Kant, R., Anand, M., King, E. C., Krogh‐Madsen, T., Christini, D. J., & Abbott, G. W. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000315 · Cited by 47
Zhang, H., Zhang, H., Wu, L., Tan, D.-X., Kamat, A., Li, Y. Q., Katz, M. S., Abboud, H. E., Reiter, R. J., & Zhang, B.-X. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00894.x · Cited by 46
Holloway, G. P., Snook, L. A., Harris, R. J., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.198663 · Cited by 46
Improved cerebral energetics and ketone body metabolism in db/db mice
Andersen, J. V., Christensen, S. K., Nissen, J. D., & Waagepetersen, H. S. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16684154 · Cited by 44
Cieluch, A., Uruska, A. A., & Zozulińska‐Ziółkiewicz, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082852 · Cited by 43
Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy
Dannenberg, L., Weske, S., Kelm, M., Levkau, B., & Polzin, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107920 · Cited by 43
Genetic and Pharmacologic Models for Type 1 Diabetes
Leiter, E. H., & Schile, A. J. (2013) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo120154 · Cited by 43
Mitochondrial Regulation of Diabetic Kidney Disease
Galvan, D. L., Mise, K., & Danesh, F. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745279 · Cited by 42
Ryu, M. J., Kim, S. J., Choi, M. J., Kim, Y. K., Lee, M. H., Lee, S. E., Chung, H. K., Jung, S. B., Kim, H. J., Kim, K. S., et al. (2013) · Molecules and Cells · doi:10.1007/s10059-012-2257-1 · Cited by 41
Peroxisomes compensate hepatic lipid overflow in mice with fatty liver
Knebel, B., Hartwig, S., Haas, J., Lehr, S., Goeddeke, S., Susanto, F., Bohne, L., Jacob, S., Koellmer, C., Nitzgen, U., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.03.003 · Cited by 40
Shepherd, D. L., Hathaway, Q. A., Nichols, C. E., Durr, A. J., Pinti, M. V., Hughes, K. M., Kunovac, A., Stine, S. M., & Hollander, J. M. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.04.016 · Cited by 39
Ilkun, O. L., Wilde, N., Tuinei, J., Pires, K. M. P., Zhu, Y., Bugger, H., Soto, J. E., Wayment, B. E., Olsen, C. D., Litwin, S. E., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.05.012 · Cited by 39
Self-citationDewey, S., Lai, X., Witzmann, F. A., Sohal, M., & Gomes, A. V. (2013) · Journal of Proteome Research · doi:10.1021/pr4004739 · Cited by 38
Chen, X., Li, J., Hou, J., Xie, Z., & Yang, F. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.22 · Cited by 38
Proteome changes in the myocardium of experimental chronic diabetes and hypertension
Ares-Carrasco, S., Picatoste, B., Camafeita, E., Carrasco, S., Zubiri, I., Ortíz, A., Egido, J., López, J. A., Tuñón, J., & Lorenzo, Ó. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.12.023 · Cited by 37
Animal Models of Dysregulated Cardiac Metabolism
Bugger, H., Byrne, N. J., & Abel, E. D. (2022) · Circulation Research · doi:10.1161/circresaha.122.320334 · Cited by 37
Self-citationMyocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1
Koentges, C., König, A., Pfeil, K., Hölscher, M. E., Schnick, T., Wende, A. R., Schrepper, A., Cimolai, M. C., Kersting, S., Hoffmann, M. M., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0495-4 · Cited by 37
Self-citationMitochondria in the pathogenesis of diabetes: a proteomic view
Chen, X., Wei, S., & Yang, F. (2012) · Protein & Cell · doi:10.1007/s13238-012-2043-4 · Cited by 36
Shaping Up Mitochondria in Diabetic Nephropathy
Mise, K., Galvan, D. L., & Danesh, F. R. (2020) · Kidney360 · doi:10.34067/kid.0002352020 · Cited by 35
Metadata
- Authors
- Bugger, H., Chen, D., Riehle, C., Soto, J., Theobald, H. A., Hu, X. X., Ganesan, B., Weimer, B. C., & Abel, E. D.
- Affiliations
- University of Utah (US)
- Utah State University (US)
- Corresponding author
- Abel, E. Dale
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-06-19
- Volume
- 58
- Issue
- 9
- Pages
- 1986-1997
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2731527
- OpenAlex
- W2102147313
- Cited by
- 180
- References
- 37
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 4 · 2023: 10 · 2022: 10 · 2021: 12 · 2020: 8 · 2019: 8 · 2018: 11 · 2017: 10 · 2016: 10 · 2015: 17 · 2014: 8 · 2013: 18 · 2012: 21
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- American Heart Association
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- National Heart, Lung, and Blood Institute (U01HL087947, U01-HL70525, U01HL070525)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- type 1 diabetes, mitochondrial proteome, mitochondrial dysfunction, Akita mice, diabetic cardiomyopathy, heart mitochondria, fatty acid oxidation, TCA cycle, oxidative phosphorylation, PGC-1α, mitochondrial respiration, ATP production, mitochondrial morphology, kidney mitochondria, liver mitochondria
- MeSH terms
- Adenosine Triphosphate, Animals, Brain, Diabetes Mellitus, Type 1, Fatty Acids, Kidney, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Microscopy, Electron, Mitochondria, Liver, Oxidative Phosphorylation, Cell Respiration, Proteome, Gene Expression Profiling, Mitochondrial Diseases, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.